National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders
NHS Englandgoods
What the buyer wrote
NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Work starts
- 1 Feb 2018
- Work ends
- 31 Jan 2019
- Kind of work
- Health and social care
Who the buyer named
Natalie Hailwood was the named contact on this notice.